Lupin Launches Dapaturn GM Range for Improved Approach to Manage Type 2 Diabetes MD Brand Connect1 Jan 2024 11:45 AM ISTGlobal pharma major Lupin Limited announced the launch of Dapaturn GM Forte for the treatment of diabetic patients in India. Lupin's Dapaturn GMâ„¢...
Liberal Transfusion Strategy in MI with anaemia: No benefits found Dr. Shravani Dali1 Jan 2024 11:15 AM ISTLiberal Transfusion Strategy fails to reduce risk of recurrence and death in MI patients with anemia suggests a new study published in The New England...
Venoarterial ECMO may not reduce mortality in patients with infarct-related cardiogenic shock Aditi1 Jan 2024 7:45 AM ISTVA-ECMO did not reduce 30-day death rate compared with medical therapy alone
Study finds elevated cardiac troponin levels in infants with acute SARS-CoV-2 infection Medha Baranwal1 Jan 2024 7:30 AM ISTItaly: A recent prospective comparative study has shown elevated troponin levels in about one in three infants infected with SARS-CoV-2. Elevations...
Potassium magnesium citrate bests potassium chloride for Prevention of thiazide induced hyperglycemia Medha Baranwal30 Dec 2023 9:00 AM ISTUSA: A recent study published in Hypertension has shown potassium magnesium citrate (KMgCit) to be superior to potassium chloride (KCl) in preventing...
Use of computerized insulin order may improve blood sugar control in hospitalized cardiac patients Medha Baranwal29 Dec 2023 10:00 PM ISTSaudi Arabia: A recent study published in Cardiovascular Endocrinology & Metabolism has shed light on the effect of implementing computerized...
BMI may independently predict non-calcified plaque presence among patients with a CAC 0: Study Medha Baranwal29 Dec 2023 9:30 PM ISTIraq: The presence of non-calcified plaque in patients with a coronary calcium score of 0 is associated with diabetes mellitus, advanced age, high...
Extended use of inclisiran safe and efficacious among refractory dyslipidemia in patients with increased CV risk Dr Riya Dave29 Dec 2023 8:45 PM ISTA recent study sheds light on the safety profile of inclisiran, an innovative agent designed to reduce low-density lipoprotein cholesterol (LDL-C)....
Aficamten improved outcomes for patients with obstructive hypertrophic cardiomyopathy: Phase 3 SEQUOIA-HCM trial Medha Baranwal29 Dec 2023 7:30 PM ISTUSA: The pivotal Phase 3 clinical trial (SEQUOIA-HCM) of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) has...
Patients with mental distress after MI likely to have PTSD, finds study Dr Riya Dave29 Dec 2023 8:45 AM ISTA recent cross-sectional epidemiological study sheds light on a concerning trend among individuals who have experienced myocardial infarction (MI)....
Hypertensive Disorders of Pregnancy Associated With Lasting Effects on Heart Dr. Kamal Kant Kohli29 Dec 2023 8:30 AM ISTNew research from the Smidt Heart Institute at Cedars-Sinai found that women who developed signs of elevated blood pressure during pregnancy were more...
Genetically predicted high BP and LDL-C increase risk of CHD independent of age Jacinthlyn Sylvia28 Dec 2023 11:00 PM ISTThe impact of blood pressure and cholesterol levels on coronary heart disease (CHD) risk across different life stages has always been a subject of...
